Literature DB >> 7377420

Diet discontinuation policies and practices of PKU clinics in the United States.

V E Schuett, R F Gurda, E S Brown.   

Abstract

Marked diversity in policies and practices for discontinuation of the PKU diet in the U.S. was found in a nationwide survey. Seventy-two of the 78 identified clinical centers treating PKU provided data. No clinicians are currently considering diet discontinuation at ages earlier than their present policy or practice. A definite trend toward later discontinuation of diet was identified. A few clinicians have always recommended indefinite diet continuation while many clinics have experience with children ages 9--12 who have discontinued the diet. Clinics with seven or more children off diet in this age range are significantly more likely than smaller clinics to be considering a later age for diet discontinuation. There were 151 children approximately age 10 or older, who remain on a low phenylalanine diet. These children are followed by 29 clinics, but over one-half of them are followed by five clinics which have had long-standing policies of indefinite diet continuation. Factors associated with success in long-term management are a firm clinic policy supporting continued diet treatment; frequent, supportive contacts with the family; open discussion by staff with families and establishment of a trusting relationship; teaching children to accept responsibility for diet management from an early age.

Entities:  

Mesh:

Year:  1980        PMID: 7377420      PMCID: PMC1619429          DOI: 10.2105/ajph.70.5.498

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  PKU as a factor in the development of self-esteem.

Authors:  J L Moen; R D Wilcox; J K Burns
Journal:  J Pediatr       Date:  1977-06       Impact factor: 4.406

2.  Management of phenylketonuria: South Australian experience of 13 cases.

Authors:  E F Robertson; G N Hill; K Cashel; J Rooney; R Brummitt; A C Pollard
Journal:  Med J Aust       Date:  1976-05-01       Impact factor: 7.738

3.  What is the best age to discontinue the low phenylalanine diet in phenylketonuria? A presentation of some contributory data.

Authors:  C F Johnson
Journal:  Clin Pediatr (Phila)       Date:  1972-03       Impact factor: 1.168

4.  Termination of dietary treatment of phenylketonuria.

Authors:  D Murphy
Journal:  Ir J Med Sci       Date:  1969-04       Impact factor: 1.568

5.  Termination of restricted diet in children with phenylketonuria: a randomized controlled study.

Authors:  N A Holtzman; D W Welcher; E D Mellits
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

6.  Discontinuing the phenylalamine-restricted diet in young children with PKY. Psychosocial aspects.

Authors:  S M Pueschel; S Yeatman; C Hum
Journal:  J Am Diet Assoc       Date:  1977-05

7.  Termination of dietary treatment in phenylketonuria.

Authors:  B Cabalska; N Duczyńska; J Borzymowska; K Zorska; A Koślacz-Folga; K Bozkowa
Journal:  Eur J Pediatr       Date:  1977-11-04       Impact factor: 3.183

8.  Growth in the skeletal and non-skeletal components of head width from 9 to 14 years of age.

Authors:  I J Singh; B S Savara; M T Newman
Journal:  Hum Biol       Date:  1967-05       Impact factor: 0.553

9.  [Phenylketonuria. Psychometric assessment of the phenylalanine-poor diet in children with phenylketonuria].

Authors:  H Bickel; S Kaiser-Grubel
Journal:  Dtsch Med Wochenschr       Date:  1971-09-03       Impact factor: 0.628

10.  Mental development of phenylketonuric children on or off diet after the age of six.

Authors:  E S Brown; R Warner
Journal:  Psychol Med       Date:  1976-05       Impact factor: 7.723

View more
  17 in total

Review 1.  Diet, sensitive periods in flavour learning, and growth.

Authors:  Jillian C Trabulsi; Julie A Mennella
Journal:  Int Rev Psychiatry       Date:  2012-06

2.  Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria.

Authors:  A S Lidsky; F D Ledley; A G DiLella; S C Kwok; S P Daiger; K J Robson; S L Woo
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia.

Authors:  L G Greeves; C C Patterson; D J Carson; R Thom; M C Wolfenden; J Zschocke; C A Graham; N C Nevin; E R Trimble
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

4.  The effects of diet discontinuation in children with phenylketonuria.

Authors:  R Koch; C G Azen; N Hurst; E G Friedman; K Fishler
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

5.  Haemostatic variables in phenylketonuric children under dietary treatment.

Authors:  K H Schulpis; H Platokouki; E D Papakonstantinou; E Adamtziki; A Bargeliotis; S Aronis
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Phenylketonuric patients decades after diet.

Authors:  R O Fisch; P N Chang; S Weisberg; P Guldberg; F Güttler; M Y Tsai
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  The use of gelatin capsules for ingestion of formula in dietary treatment of maternal phenylketonuria.

Authors:  H H Kecskemethy; D Lobbregt; H L Levy
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.

Authors:  F Rey; V Abadie; F Plainguet; J Rey
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Diet policies of PKU clinics in the United States.

Authors:  V E Schuett; E S Brown
Journal:  Am J Public Health       Date:  1984-05       Impact factor: 9.308

10.  Insurance coverage of special foods needed in the treatment of phenylketonuria.

Authors:  B N Millner
Journal:  Public Health Rep       Date:  1993 Jan-Feb       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.